Connecticut Senate Bill SB00574

Connecticut 2013 Regular Session

• Introduced: 1/24/13
• Refer: 1/24/13

Caption

An Act Concerning An Exemption From The Sales Tax For Nonprescription Drugs.

Impact

The impact of SB00574, if enacted, would be significant in terms of consumer savings on over-the-counter drugs. This change could lead to a noticeable reduction in expenses for families and individuals who regularly purchase nonprescription medications. Supporters of the bill argue that this exemption could promote public health by making essential medications more affordable and thus potentially increasing their usage among those who may have previously foregone treatment due to cost concerns.

Summary

SB00574 aims to amend section 12-412 of the general statutes to restore the sales tax exemption for nonprescription drugs. The primary focus of the bill is to alleviate the financial burden on consumers purchasing over-the-counter medications. By removing the sales tax from these products, the bill seeks to improve accessibility and affordability for individuals in need of such health-related items, particularly those without insurance or with limited financial means to cover additional costs.

Contention

Despite the potential benefits of SB00574, the bill may face contention regarding its fiscal implications on state revenue. Critics might argue that while the tax exemption supports consumer health, it could result in reduced income for state funding and public services dependent on sales tax revenues. This raise concerns among lawmakers and stakeholders who are tasked with balancing budgetary needs against public health initiatives. Debates may focus on whether the long-term health benefits justify the immediate financial impact on state resources.